X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9375) 9375
Publication (603) 603
Book Chapter (155) 155
Dissertation (122) 122
Book Review (102) 102
Conference Proceeding (92) 92
Book / eBook (9) 9
Web Resource (6) 6
Data Set (5) 5
Magazine Article (3) 3
Government Document (2) 2
Paper (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4585) 4585
drug interactions (3420) 3420
pharmacology & pharmacy (3411) 3411
drug-drug interactions (2870) 2870
index medicus (2855) 2855
animals (2666) 2666
male (2289) 2289
drug-drug interaction (2177) 2177
pharmacokinetics (1554) 1554
female (1494) 1494
rats (1091) 1091
receptors, drug - drug effects (1052) 1052
adult (973) 973
middle aged (858) 858
metabolism (827) 827
in-vitro (714) 714
aged (643) 643
dose-response relationship, drug (592) 592
pharmacology (591) 591
drug–drug interaction (583) 583
analysis (570) 570
inhibition (556) 556
mice (550) 550
drugs (512) 512
drug–drug interactions (495) 495
toxicology (492) 492
kinetics (482) 482
p-glycoprotein (473) 473
cytochrome p450 (431) 431
in vitro techniques (424) 424
biochemistry & molecular biology (419) 419
drug interaction (407) 407
cytochrome p-450 enzyme system - metabolism (406) 406
cytochrome p-450 (395) 395
young adult (375) 375
area under curve (371) 371
drug therapy, combination (360) 360
models, biological (358) 358
pharmacology/toxicology (344) 344
research (341) 341
chemistry, multidisciplinary (334) 334
enzymes (319) 319
receptors, drug - metabolism (314) 314
drug therapy (310) 310
liver (305) 305
human liver-microsomes (304) 304
rats, sprague-dawley (295) 295
adolescent (291) 291
prediction (291) 291
administration, oral (279) 279
time factors (271) 271
metabolites (266) 266
pharmacy (266) 266
therapy (263) 263
cytochrome p-450 cyp3a - metabolism (262) 262
polypharmacy (258) 258
liver - metabolism (255) 255
cells, cultured (254) 254
chemistry, medicinal (254) 254
cancer (252) 252
pharmaceutical preparations - metabolism (250) 250
cross-over studies (247) 247
physiological aspects (245) 245
cyp3a4 (244) 244
microsomes, liver - metabolism (241) 241
complications and side effects (240) 240
pharmacodynamics (236) 236
medicine & public health (231) 231
drug design (230) 230
aged, 80 and over (229) 229
protein binding (229) 229
oncology (227) 227
safety (222) 222
biomedicine (221) 221
enzyme inhibitors - pharmacology (216) 216
expression (215) 215
microsomes, liver - drug effects (213) 213
article (212) 212
risk factors (212) 212
internal medicine (210) 210
microsomes, liver - enzymology (206) 206
drug metabolism (202) 202
induction (201) 201
binding sites (200) 200
drug synergism (197) 197
warfarin (193) 193
structure-activity relationship (188) 188
care and treatment (187) 187
cell line (187) 187
rats, wistar (185) 185
risk (185) 185
dosage and administration (184) 184
healthy-volunteers (177) 177
absorption (175) 175
health aspects (174) 174
inhibitors (173) 173
hiv (172) 172
prevalence (172) 172
binding (170) 170
ketoconazole (170) 170
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6306) 6306
Japanese (1797) 1797
Chinese (1414) 1414
German (63) 63
French (41) 41
Russian (27) 27
Spanish (22) 22
Slovenian (9) 9
Czech (7) 7
Korean (6) 6
Portuguese (6) 6
Polish (5) 5
Hungarian (2) 2
Italian (2) 2
Bulgarian (1) 1
Norwegian (1) 1
Slovak (1) 1
Thai (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 1/2011, Volume 50, Issue 1, pp. 25 - 39
Etravirine (formerly TMC125) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) with activity against wild-type and NNRTI-resistant strains of HIV-1.... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Drug-interactions | Ribavirin, drug interactions | Antiepileptic-drugs, drug interactions | Simvastatin, drug interactions | Voriconazole, drug interactions | Dexamethasone, drug interactions | Fibric-acid-derivatives, drug interactions | Rifampicin, drug interactions | Opioid-analgesics, drug interactions | Antidepressants, drug interactions | Atorvastatin, drug interactions | Antiretrovirals, drug interactions | Anti-infectives, drug interactions | Histamine-H2-receptor-antagonists, drug interactions | Diazepam, drug interactions | Ketoconazole, drug interactions | Fluconazole, drug interactions | Hypericum, drug interactions | HMG-CoA-reductase-inhibitors, drug interactions | Oral-contraceptives, drug interactions | Sildenafil, drug interactions | Omeprazole, drug interactions | Buprenorphine, drug interactions | Rosuvastatin, drug interactions | Non-nucleoside-reverse-transcriptase-inhibitors, drug interactions | Type-5-cyclic-nucleotide- phosphodiesterase-inhibitors, drug interactions | Corticosteroids, drug interactions | Paroxetine, drug interactions | Fluoxetine, drug interactions | Rifapentine, drug interactions | Ethinylestradiolnorethisterone, drug interactions | Ranitidine, drug interactions | Etravirine, drug interactions | Antifungals, drug interactions | Digoxin, drug interactions | Warfarin, drug interactions | Methadone, drug interactions | Fluvastatin, drug interactions | Rifabutin, drug interactions | Sertraline, drug interactions | Azithromycin, drug interactions | Pharmacokinetics | Calcineurin-inhibitors, drug interactions | Itraconazole, drug interactions | Proton-pump-inhibitors, drug interactions | Clarithromycin, drug interactions | TRANSCRIPTASE INHIBITOR ETRAVIRINE | METABOLISM | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | HIV-NEGATIVE VOLUNTEERS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HUMAN LIVER | PLACEBO-CONTROLLED TRIAL | 2 DIFFERENT FORMULATIONS | CLINICAL PHARMACOKINETICS | Reverse Transcriptase Inhibitors - adverse effects | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Drug-Related Side Effects and Adverse Reactions | Humans | Pyridazines - pharmacokinetics | Drug Therapy, Combination | Pyridazines - adverse effects | Etravirine | Drug interactions | Physiological aspects | Dosage and administration | Research | Properties | Drug therapy | HIV infection
Journal Article
Journal Article
by Zhang, YP and Li, SP and Wang, YX and Deng, G and Cao, N and Wu, C and Ding, WZ and Wang, YW and Cheng, XM and Wang, CH
MOLECULES, ISSN 1420-3049, 04/2019, Volume 24, Issue 7, p. 1430
Harmine (HAR) is a beta-carboline alkaloid widely distributed in nature. It exhibits psychopharmacological effects of improving learning and memory. However,... 
SYSTEM | DEMENTIA | RAT | memantine | liquid chromatography-mass spectrometry | ALZHEIMERS-DISEASE | HARMALINE | BIOCHEMISTRY & MOLECULAR BIOLOGY | harmine | MODEL | CHEMISTRY, MULTIDISCIPLINARY | BETA-CARBOLINE ALKALOIDS | MEMORY | pharmacokinetics | SPECIES-DIFFERENCES | MPTP | drug-drug interaction | Alzheimer's disease | Alzheimer’s disease
Journal Article
Journal Article
Journal Article
Journal Article